Research focus
About the research
How can molecular and nanoscale engineering improve the therapeutic potential of drug combinations, vaccines, and immunotherapies?
Read the full research overview
Erik Dreaden joined the Department of Biomedical Engineering at Georgia Institute of Technology and Emory University in 2017. He also holds a joint faculty appointment in the Department of Pediatrics at the Emory University School of Medicine. The lab uses molecular engineering to impart augmented, amplified, or non-natural function to tumor therapies and immunotherapies. He is a member of the Cancer Immunology Research Program at the Winship Cancer Institute of Emory University.
Selected publications
3 listedEngineered Cytokines for Cancer and Autoimmune Disease Immunotherapy
Advanced Healthcare Materials
PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives
Frontiers in Bioengineering and Biotechnology
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12
Scientific Reports
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings